EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease.
No abstract available.
The Journal of allergy and clinical immunology
Thomas DC, Charbonnier LM, Schejtman A, Aldhekri H, Coomber EL, Dufficy ER, Beenken AE, Lee JC, Clare S, Speak AO, Thrasher AJ, Santilli G, Al-Mousa H, Alkuraya FS, Chatila TA, Smith KGC. (2019). EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease. The Journal of allergy and clinical immunology, 143(2)
ProfessorUniversity of Pittsburgh Continue Reading Kenneth Smith